• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 9 of 100
Merck snags Chinese obesity drug in nearly $2 billion deal
TechMerck snags Chinese obesity drug in nearly $2 billion deal
By Robert Langreth and BloombergDecember 18, 2024
As you dive into your New Year’s resolutions, taking precautions to protect yourself from a quartet of infectious diseases can lessen your odds of starting off 2025 sick.
HealthPublic health experts are warning of a ‘quad-demic’ this winter. Here’s where flu, COVID, RSV, and norovirus are spreading
By Lindsey LeakeDecember 18, 2024
NXTL 2024. From left to right: Apple's John Ternus, Amazon's Jamil Ghani, Walmart's Latriece Watkins and Megan Crozier, Nike's Craig Williams, and WinField's Leah Anderson.
NewslettersFortune Next to Lead: The 25 Most Powerful Rising Executives in the Fortune 500
By Ruth Umoh and Natalie McCormickDecember 17, 2024
The polio vaccine has all but obliterated the illness that once killed thousands and paralyzed 15,000 people nationwide every year.
HealthPolio is a deadly disease with a vaccine that RFK Jr.’s adviser wants to ban. Here’s how the immunization works
By Lindsey LeakeDecember 13, 2024
Older man sitting at table holding his arm still as he eats soup
HealthHope for Parkinson’s disease symptoms is found in late-stage drug study
By Beth GreenfieldDecember 10, 2024
Close-up of a patient administering a dose of Zepbound (tirzepatide)
HealthZepbound vs. Wegovy: New clinical trial says this weight-loss medication sheds more pounds
By Lindsey LeakeDecember 4, 2024
Abortion went first. Contraceptives could be next—unless men step up
CommentaryAbortion went first. Contraceptives could be next—unless men step up
By Akash BakshiDecember 4, 2024
A twice-yearly shot of this drug could help end AIDS — ‘it’s unprecedented’
HealthA twice-yearly shot of this drug could help end AIDS — ‘it’s unprecedented’
By Maria Cheng, María Verza and The Associated PressDecember 1, 2024
Swiss pharma giant Novartis says 30 pipeline drugs with ‘significant potential’ will drive long-term growth
FinanceSwiss pharma giant Novartis says 30 pipeline drugs with ‘significant potential’ will drive long-term growth
By AFPNovember 21, 2024
Fortune Global Forum 2024 Tuesday, November 12, 2024 New York, NY 12:05 PM – 1:20 PM LUNCH STRATEGY SESSIONS PIONEERING TECH THAT DELIVERS NEXT-GEN SOLUTIONS As technology advances, the need to bring new classes of products to customers in both agile and innovative ways becomes crucial. Escalating trade tensions, climate change, geopolitical turmoil, and labor disputes are also throwing traditional commercialization models into disarray. These conflicts are, in turn, putting pressure on production lines, supply chains, and infrastructure, with domino effects across industries and borders. To remain competitive, business leaders must navigate these new complexities in order to deliver everything from life-saving medications to consumer products on time–and at scale. In this session, we’ll learn how some companies have been able to deliver next gen solutions while meeting the demands of a changing marketplace. Presented by Novartis Discussion Leaders: Victor Bulto, President, U.S., Novartis Jennifer Nuckles, Chief Executive Officer, R-Zero Charles van der Steene, President, North America, Maersk Krish Venkataraman, President, Dataiku Moderator: Alex Wood Morton, Fortune Photograph by Michael O’Shea for Fortune
ConferencesFrom biopharma to real estate to shipping, top CEOs insist AI is worth the hype
By Jane ThierNovember 15, 2024
FDA announces new rules to make TV drug ads clearer as Trump nominates RFK Jr., who wants to ban them
HealthFDA announces new rules to make TV drug ads clearer as Trump nominates RFK Jr., who wants to ban them
By Matthew Perrone and The Associated PressNovember 15, 2024
businessman wearing a suit with his arms crossed posed for a photo
NewslettersWhy this major drugmaker no longer has an ‘IT department’
By John KellNovember 13, 2024
Why Eli Lilly’s CEO says failing faster is essential to the company’s success
LeadershipWhy Eli Lilly’s CEO says failing faster is essential to the company’s success
By Fortune EditorsNovember 13, 2024
AstraZeneca says it’s taking China’s investigations into fraud, illegal drug importation and data collection ‘very seriously’
RetailAstraZeneca says it’s taking China’s investigations into fraud, illegal drug importation and data collection ‘very seriously’
By AFPNovember 12, 2024
Robert F. Kennedy Jr. speaks during a campaign rally for Republican presidential nominee, former President Donald Trump at Macomb Community College in Michigan.
PoliticsRFK Jr. could play a big role under Trump—and Big Pharma is sounding the alarm: ‘We need somebody grounded by science and evidence, not somebody who rejects it’
By Christiaan HetznerNovember 8, 2024
1...
  • 7
  • 8
  • 9
  • 10
  • 11
...100
Most Popular
Future of Work
'Employers are increasingly turning to degree and GPA' in hiring: Recruiters retreat from ‘talent is everywhere,’ double down on top collegesplaceholder alt text
By Jake AngeloMay 9, 2026
Politics
Ted Cruz says the quiet part out loud: Trump accounts are Social Security personal accounts as GOP senator reveals 'dirty little secret'placeholder alt text
By Jason MaMay 9, 2026
Success
Red flag test: former CEO explains why he rejects job candidates who say they can start right awayplaceholder alt text
By Orianna Rosa RoyleMay 9, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.